Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

Thrombate

Plasma-derived product · Protein replacement

Phase 2 Most advanced trial
1 Registered trials

What is Thrombate?

Thrombate is an intravenous antithrombin preparation, given as a bolus infusion dosed by patient weight to raise antithrombin activity levels.

Summary written with AI from the sources listed at the end of this page.

At a glance

Drug type
Plasma-derived product
Mechanism
Protein replacement
Therapy area
Cardiovascular
In trials of
GRFS
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 2

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05794165 Phase 2 Trauma Injury Enrolling by invitation GRFS

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

ThromboembolismTrauma InjuryVenous Thromboembolism

Sources

Updated Oct 11, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.